{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":33,"n_cols":5,"rows_kept":33,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[13,2,13,3],[13,4,13,5],[14,2,14,3],[14,4,14,5],[15,2,15,3],[16,2,16,3],[17,2,17,3],[18,2,18,3],[19,2,19,3],[20,2,20,3],[26,2,26,3],[27,2,27,3],[30,2,30,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910810574703321"]
[null,null,"Autore",null,"Berger Stephen A."]
[null,null,"Titolo",null,"Endemic typhus group : global status / / Stephen Berger"]
[null,null,"Pubbl/distr/stampa",null,"Los Angeles : , : Gideon Informatics, Inc, , [2021]"]
[{"$nulls":4},"©2021"]
[null,null,"ISBN",null,"1-4988-3376-4"]
[null,null,"Descrizione fisica",null,"1 online resource (99 pages) : illustrations"]
[null,null,"Collana",null,"Gideon e-book series"]
[null,null,"Disciplina",null,"614.5262"]
[null,null,"Soggetti",null,"Typhus fever"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910300068803321"]
[null,null,"Titolo",null,"Living Donor Advocacy : An Evolving Role Within Transplantation / / edited by JENNIFER STEEL"]
[null,null,"Pubbl/distr/stampa",null,"New York, NY : , : Springer New York : , : Imprint : Springer, , 2014"]
[null,null,"ISBN",null,"1-4614-9143-6"]
[null,null,"Edizione",null,"[1st ed. 2014.]"]
[null,null,"Descrizione fisica",null,"1 online resource (357 p.)"]
[null,null,"Disciplina",null,"362.19795"]
[null,null,"Soggetti",null,"Transplantation of organs, tissues, etc"]
[{"$nulls":4},"Medicine"]
[{"$nulls":4},"Nephrology"]
[{"$nulls":4},"Hepatology"]
[{"$nulls":4},"Transplant Surgery"]
[{"$nulls":4},"Medicine/Public Health, general"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Part I: Living Donation: Chapter 1: The Medical Selection of Live Donors,- Chapter 2: Kidney Paired Donation Programs for Incompatible Living Kidney Donors and Recipients -- Chapter 3: Living Donor Liver Transplantation -- Chapter 4: Intestinal Transplantation from Living Donors -- Chapter 5: Living Donor Lung Transplantation -- Chapter 6: Live Donor Pancreas Transplantation -- Part II: Living Donor Advocacy: Chapter 7: The History of Living Donor Advocacy in Living Donor Transplantation -- Chapter 8: Findings from a National Survey of Living Donor Advocates -- Chapter 9: The Independent Donor Advocate and the Independent Donor Advocate Team -- Chapter 10: Classification of Living Organ Donors -- Chapter 11: Unrelated Donors -- Chapter 12: Education of the Donor by the ILDA (Psychosocial Aspects) -- Chapter 13: Components and Timing of the ILDA Evaluation -- Chapter 14: Contraindications to Living Donation from an ILDA Perspective -- Chapter 15: Management of Conflict Between the Independent Living Donor Advocate and the Transplant Team -- Chapter 16: Story Behind the Story -- Chapter 17: Living Donor Experience -- Part III: Living Donor Ethics: Chapter 18: Informed Consent for Living Organ Donation -- Chapter 19: Pressure and Coercion -- Chapter 20: Financial Considerations -- Chapter 21: Autonomy, Agency, and Responsibility: Ethical Concerns for Living Donor Advocates -- Chapter 22: A Practical "]
[{"$nulls":4},"Guide: Role of the Independent Living Donor Advocate: Protect or Advocate or Is It Both/And? -- Chapter 23: Racial Disparities in Kidney Transplant and Living Donation -- Chapter 24: The Evolution of the Role of the Independent Living Donor Advocates: Recommendations for Practice Guidelines."]
[null,null,null,"Sommario/riassunto","  The inadequate supply of organs in the United States and other countries continues to drive the reliance on living donor transplantation.  Representatives of the transplant community convened for a meeting on living donation in an effort to provide guidelines to promote the welfare of living donors.  The consensus statement that resulted from this meeting recommended that transplant centers retain an Independent Living Donor Advocate (ILDA) to focus on the best interest of the donor.  Over a decade later, nearly every transplant center in the United States, performing living donor surgeries, has incorporated an ILDA into their living donor screening and/or evaluation process, however there are no guidelines with regard to the ILDA’s qualifications, clinical practice, or how address ethical challenges.      Living Donor Advocacy is an overview of living donation and its risks, ethical challenges and future directions regarding this role within the transplantation process.  This book provides health care professionals or consumers of health care with information that facilitates their understanding of the complexity of the living donor surgeries and medical contraindications, evaluation of the donor, and bioethics involved in living donation.    Living Donor Advocacy brings the fragmented information in the literature together into a single, invaluable resource for health professionals and those undergoing transplantation or living donor surgery."]